Marcoleta asked the DOH to explain their preference for an expensive COVID-19 treatment.
Deputy Speaker and 1Sagip Partylist Representative Rodante Marcoleta asked the Department of Health (DOH) to explain their preference for an expensive COVID-19 treatment.
In a report on Manila Bulletin, Marcoleta had asked the Department of Health and other health professionals to explain their preference in prescribing Remdesivir notwithstanding the World Health Organization (WHO)’s advisory against its use for people battling the deadly coronavirus disease.
According to Marcoleta, officials of the Department of Health and the Food and Drug Administration (FDA) should also make public disclosure of their links with the so-called “Big Pharma”, stressing that they should be forthright in telling the public which firms financed research grants, trips, and funding of projects they initiated.
READ ALSO: President Duterte Hopeful Ivermectin Can Be Used As “Palliative”, “Preventive” Drug vs COVID-19
Marcoleta aired the challenge as he chided the Department of Health for failing to heed the World Health Organization (WHO)’s advice against the use of Remdisivir, supposedly a COVID-19 treatment.
He described it as a “highly priced drug” that cost between PHP 16,000 to PHP 48,000 per shot.
Marcoleta suspected that leading pharmaceutical companies have something to do with the critical stance of the Philippines’ health authorities against the use of Ivermectin to prevent and cure COVID-19.
He, together with Anakalusugan Partylist Representative Mike Defensor, came under fire from the Philippine College of Physicians and DOH officials for distributing free Ivermectin capsules in Quezon City last week.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
